Xueqiang Zhao

机构：Peking University, Ark Medical Center, Beijing Haidian Hospital, Atotech (United States), Tsinghua University · ORCID：0000-0002-1818-3015

发表论文 21 篇 · 总被引 966 次 · h-index 12

代表论文

• Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment (2021 · Cellular and Molecular Immunology · 被引 237)
• CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma (2020 · European Journal of Immunology · 被引 193)
• Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors (2021 · Science Translational Medicine · 被引 162)
• IFNγ Promotes Papilloma Development by Up-regulating Th17-Associated Inflammation (2009 · Cancer Research · 被引 100)
• Linear ubiquitination of cFLIP induced by LUBAC contributes to TNFα-induced apoptosis (2018 · Journal of Biological Chemistry · 被引 49)
• A novel adoptive synthetic TCR and antigen receptor ( STAR ) T‐Cell therapy for B‐Cell acute lymphoblastic leukemia (2022 · American Journal of Hematology · 被引 42)